Nanoparticulate Delivery Systems For Antiviral Drugs

We have collected information about Nanoparticulate Delivery Systems For Antiviral Drugs for you. Follow the links to find out details on Nanoparticulate Delivery Systems For Antiviral Drugs.


Nanoparticulate Delivery Systems for Antiviral Drugs ...

    https://journals.sagepub.com/doi/10.3851/IMP1684?icid=int.sj-full-text.similar-articles.1
    Further improvements to a therapy can also be obtained through the use of innovative delivery systems for antiviral administration; for example, the use of nanotechnology has led to the development of nanoparticulate carriers. Nanotechnological approaches can be used to improve the design, formulation and delivery of antiviral drugs.

Nanoparticulate Delivery Systems for Antiviral Drugs ...

    https://journals.sagepub.com/doi/abs/10.3851/IMP1684
    Dec 01, 2010 · Nanoparticulate-based systems might change the release kinetics of antivirals, increase their bioavailability, improve their efficacy, restrict adverse drug side effects and reduce treatment costs. Moreover, they could permit the delivery of antiviral drugs …Author: David Lembo, Roberta Cavalli

(PDF) Nanoparticulate Delivery Systems for Antiviral Drugs

    https://www.researchgate.net/publication/49635233_Nanoparticulate_Delivery_Systems_for_Antiviral_Drugs
    Lembo and Cavalli [18] present the current status up to 2010 in the nanoparticulate delivery systems in antiviral therapy area, highlighting their perspective on the challenges that must be ...

Multifunctional, stimuli-sensitive nanoparticulate systems ...

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489143/
    The use of nanoparticulate pharmaceutical drug delivery systems (NDDSs) to enhance the in vivo effectiveness of drugs is now well established. The development of multifunctional and stimulus-sensitive NDDSs is an active area of current research.Author: Vladimir P. Torchilin, Vladimir P. Torchilin

Recent advances in drug delivery systems in antiviral therapy

    http://isfcppharmaspire.com/issueforpublication.aspx?Article=PHARMASPIRE_12_2018
    The delivery of antiviral drugs in different carrier systems has solved the problems associated with the conventional therapy. The results from clinical trials clearly depict that there is a better futuristic scope for the delivery of antiviral drugs in novel dosage form.

Nanoparticulate systems for brain delivery of drugs ...

    https://www.sciencedirect.com/science/article/pii/S0169409X00001228
    Mar 23, 2001 · Drugs may be bound in form of a solid solution or dispersion or be adsorbed to the surface or chemically attached. Poly(butyl cyanoacrylate) nanoparticles represent the only nanoparticles that were so far successfully used for the in vivo delivery of drugs to the brain. This polymer has the advantage that it is very rapidly biodegradable , .Author: Jörg Kreuter

Recent Advances in Nanoparticulate Drug Delivery System ...

    https://www.researchgate.net/publication/269399026_Recent_Advances_in_Nanoparticulate_Drug_Delivery_System_for_Antiviral_Drugs
    Request PDF Recent Advances in Nanoparticulate Drug Delivery System for Antiviral Drugs Nanomedicines has given an innovative way to prevent the diseases caused by viruses by …

Nanoparticles: Emerging carriers for drug delivery ...

    https://www.sciencedirect.com/science/article/pii/S1319016411000302
    1. Nanoparticles. Conventional preparations like solution, suspension or emulsion suffer from certain limitations like high dose and low availability, first pass effect, intolerance, instability, and they exhibit fluctuations in plasma drug levels and do not provide sustained effect, therefore there is a need for some novel carriers which could meet ideal requirement of drug delivery system.Author: Sagar R. Mudshinge, Amol B. Deore, Sachin Patil, Chetan M. Bhalgat

Nanoparticulate systems for brain delivery of drugs.

    https://www.ncbi.nlm.nih.gov/pubmed/11251246/
    Mar 23, 2001 · Nanoparticulate systems for brain delivery of drugs. ... One of the possibilities to overcome this barrier is a drug delivery to the brain using nanoparticles. Drugs that have successfully been transported into the brain using this carrier include the hexapeptide dalargin, the dipeptide kytorphin, loperamide, tubocurarine, the NMDA receptor ...Author: Jörg Kreuter

Nanoparticulate Drug Delivery - 1st Edition

    https://www.elsevier.com/books/nanoparticulate-drug-delivery/patravale/978-1-907568-98-5
    Nanoparticulate drug delivery highlights and examines the transition of nanoparticulate drug delivery systems from the laboratory into a commercially viable sector. The first chapters of the book provide an overview of the use and characterization of nanoparticulate systems as drug carriers, including the assessment of their morphology ...

Searching for Nanoparticulate Delivery Systems For Antiviral Drugs?

You can just click the links above. The data is collected for you.

Related Delivery Info